BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Ouyang Y, Liu B, Ma X, Ding R. Platelet activation and antiplatelet therapy in sepsis: A narrative review. Thrombosis Research 2018;166:28-36. [DOI: 10.1016/j.thromres.2018.04.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Lavie I, Lavie M, Gafter-gvili A, Halperin E, Abramovich-yoffe H, Avni T. Chronic aspirin use and survival following sepsis – A propensity-matched, observational cohort study. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.04.010] [Reference Citation Analysis]
2 Kobayashi M, Kudo D, Ohbe H, Kushimoto S. Antiplatelet pretreatment and mortality in patients with severe sepsis: A secondary analysis from a multicenter, prospective survey of severe sepsis in Japan. J Crit Care 2022;69:154015. [PMID: 35344826 DOI: 10.1016/j.jcrc.2022.154015] [Reference Citation Analysis]
3 Yuan S, Chen C, Xu F, Han D, Yang R, Zheng S, Qiao M, Huang X, Lyu J, Hostiuc S. Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease. International Journal of Clinical Practice 2022;2022:1-6. [DOI: 10.1155/2022/1288535] [Reference Citation Analysis]
4 Zhao Z, Zhang X, Zhang H, Shan X, Bai M, Wang Z, Yang F, Zhang H, Kan Q, Sun B, Sun J, He Z, Luo C. Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis. Adv Sci (Weinh) 2022;9:e2104264. [PMID: 34802198 DOI: 10.1002/advs.202104264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ishikura H, Irie Y, Kawamura M, Hoshino K, Nakamura Y, Mizunuma M, Maruyama J, Nakashio M, Suzuki-Inoue K, Kitamura T. Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count. Platelets 2022;:1-10. [PMID: 35073814 DOI: 10.1080/09537104.2021.2019694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Doganyigit Z, Eroglu E, Akyuz E. Inflammatory mediators of cytokines and chemokines in sepsis: From bench to bedside. Hum Exp Toxicol 2022;41:9603271221078871. [PMID: 35337213 DOI: 10.1177/09603271221078871] [Reference Citation Analysis]
7 Barale C, Melchionda E, Morotti A, Russo I. Prothrombotic Phenotype in COVID-19: Focus on Platelets. Int J Mol Sci 2021;22:13638. [PMID: 34948438 DOI: 10.3390/ijms222413638] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Tao Y, Li X, Wu Z, Chen C, Tan K, Wan M, Zhou M, Mao C. Nitric oxide-driven nanomotors with bowl-shaped mesoporous silica for targeted thrombolysis. J Colloid Interface Sci 2021;611:61-70. [PMID: 34929439 DOI: 10.1016/j.jcis.2021.12.065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li Q, Tong Y, Liu S, Yang K, Liu C, Zhang J. Association between body mass index and short-term mortality in patients with intra-abdominal infections: a retrospective, single-centre cohort study using the Medical Information Mart for Intensive Care database. BMJ Open 2021;11:e046623. [PMID: 34389563 DOI: 10.1136/bmjopen-2020-046623] [Reference Citation Analysis]
10 Li X, Zhang G, Cao X. The Function and Regulation of Platelet P2Y12 Receptor. Cardiovasc Drugs Ther 2021. [PMID: 34319489 DOI: 10.1007/s10557-021-07229-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Adelborg K, Larsen JB, Hvas AM. Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Br J Haematol. 2021;192:803-818. [PMID: 33555051 DOI: 10.1111/bjh.17172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
12 Bongiovanni D, Klug M, Lazareva O, Weidlich S, Biasi M, Ursu S, Warth S, Buske C, Lukas M, Spinner CD, Scheidt MV, Condorelli G, Baumbach J, Laugwitz KL, List M, Bernlochner I. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death Dis 2021;12:50. [PMID: 33414384 DOI: 10.1038/s41419-020-03333-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]
13 Motta NAV, Autran LJ, Brazão SC, Lopes RO, Scaramello CBV, Lima GF, Brito FCF. Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol 2021;92:107336. [PMID: 33418248 DOI: 10.1016/j.intimp.2020.107336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Yuan Y, Feng Z, Wang J. Vibrio vulnificus Hemolysin: Biological Activity, Regulation of vvhA Expression, and Role in Pathogenesis. Front Immunol 2020;11:599439. [PMID: 33193453 DOI: 10.3389/fimmu.2020.599439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
15 Chang JC. Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis. Thromb J 2020;18:25. [PMID: 33061857 DOI: 10.1186/s12959-020-00231-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
16 Spari D, Beldi G. Extracellular ATP as an Inter-Kingdom Signaling Molecule: Release Mechanisms by Bacteria and Its Implication on the Host. Int J Mol Sci 2020;21:E5590. [PMID: 32759857 DOI: 10.3390/ijms21155590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Jo S, Jeong T, Lee JB, Jin Y, Yoon J, Park B. The prognostic value of platelet-to-lymphocyte ratio on in-hospital mortality in admitted adult traffic accident patients. PLoS One 2020;15:e0233838. [PMID: 32555645 DOI: 10.1371/journal.pone.0233838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhao Z, Yang F, Zhang X, Sun J, He Z, Luo C. Emerging nanotherapeutics for antithrombotic treatment. Biomaterials 2020;255:120200. [PMID: 32563945 DOI: 10.1016/j.biomaterials.2020.120200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
19 Mansour A, Bachelot-Loza C, Nesseler N, Gaussem P, Gouin-Thibault I. P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation. Int J Mol Sci 2020;21:E1391. [PMID: 32092903 DOI: 10.3390/ijms21041391] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
20 Tiwari NR, Chaudhari KS, Sharma R, Haas KP, Sharma VR. Antiplatelet Agents in Sepsis-Putting it all together: A Call to Action. Indian J Crit Care Med 2020;24:483-4. [PMID: 32863646 DOI: 10.5005/jp-journals-10071-23450] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Qiu L, Han JX, See AAQ, King NKK. Effects of anticoagulant and antiplatelet agents in severe traumatic brain injury in an asian population – A matched case-control study. Journal of Clinical Neuroscience 2019;70:61-6. [DOI: 10.1016/j.jocn.2019.08.087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Yadav VK, Singh PK, Agarwal V, Singh SK. Crosstalk between Platelet and Bacteria: A Therapeutic Prospect. Curr Pharm Des 2019;25:4041-52. [PMID: 31553286 DOI: 10.2174/1381612825666190925163347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Nedeva C, Menassa J, Puthalakath H. Sepsis: Inflammation Is a Necessary Evil. Front Cell Dev Biol 2019;7:108. [PMID: 31281814 DOI: 10.3389/fcell.2019.00108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 80] [Article Influence: 17.0] [Reference Citation Analysis]
24 Zheng J, Long X, Wang X. Chemical profiling and anticoagulant activity of Ginkgo Biloba leaves under the influence of harvesting time. Journal of Liquid Chromatography & Related Technologies 2019;42:55-62. [DOI: 10.1080/10826076.2019.1570936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Zhou W, Zhou W, Bai J, Ma S, Liu Q, Ma X. TEG in the monitoring of coagulation changes in patients with sepsis and the clinical significance. Exp Ther Med 2019;17:3373-82. [PMID: 30988714 DOI: 10.3892/etm.2019.7342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Chen P, Ren S, Song H, Chen C, Chen F, Xu Q, Kong Y, Sun H. Synthesis and biological evaluation of BMS-986120 and its deuterated derivatives as PAR4 antagonists. Bioorganic & Medicinal Chemistry 2019;27:116-24. [DOI: 10.1016/j.bmc.2018.11.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
27 Ouyang Y, Wang Y, Liu B, Ma X, Ding R. Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis. J Crit Care 2019;50:162-8. [PMID: 30551047 DOI: 10.1016/j.jcrc.2018.12.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
28 Ding R, Wang Z, Lin Y, Liu B, Zhang Z, Ma X. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study. Blood Coagul Fibrinolysis 2018;29:551-8. [PMID: 30015646 DOI: 10.1097/MBC.0000000000000755] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]